ZURICH/BERLIN, April 29 (Reuters) - Here are some of the
main factors that may affect Swiss stocks on Thursday:
LONZA LONN.S
Contract drug manufacturer Lonza plans to double Swiss
production capacity for Moderna's MRNA.O COVID-19 vaccine,
helping the U.S. drugmaker boost total output to as many as 3
billion doses in 2022. urn:newsml:reuters.com:*:nL1N2ML2XZ urn:newsml:reuters.com:*:nL8N2MM17W
SWISSCOM SCMN.S
Swisscom upgraded its 2021 outlook on Thursday, now
forecasting net revenue of around 11.3 billion Swiss francs
($12.42 billion), earnings before interest, tax, depreciation
and amortisation (EBITDA) of 4.3-4.4 billion francs and capital
expenditure of 2.2-2.3 billion. urn:newsml:reuters.com:*:nL8N2MM1GC
LOGITECH LOGN.S
Logitech International reported better-than-expected
full-year sales on Thursday as the computer peripherals maker
benefited from the work-from-home trend during the COVID-19
pandemic. urn:newsml:reuters.com:*:nL4N2MM0GX
SNB SNBN.S
The Swiss National Bank SNBN.S reported a first-quarter
profit of 37.7 billion Swiss francs, it said on Thursday, as a
weaker Swiss franc boosted the value gains from its massive
foreign currency investments. urn:newsml:reuters.com:*:nL8N2MM1P1
SYNGENTA
Syngenta Group's sales increased by 20% during the first
quarter, the agrichemicals company said on Thursday, as farmers
rebuilt their stocks of seeds and pesticides after running them
down during the pandemic last year. urn:newsml:reuters.com:*:nZ8N2K901Y
NESTLE NESN.S
Nestle is shutting a factory in the north east of England,
putting nearly 600 jobs at risk, as the world's biggest packed
food company restructures its confectionery business in Britain.
urn:newsml:reuters.com:*:nL8N2ML6NT
POLYPEPTIDE PPGN.S
Contract drugmaker PolyPeptide Group priced its Swiss
initial public offering at 64.00 Swiss francs per share before
it started trading on the Swiss stock exchange on Thursday.
urn:newsml:reuters.com:*:nASN0014OC
COMPANY STATEMENTS
* Clariant CLN.S said it expects moderate sales growth in
2021. urn:newsml:reuters.com:*:nFWN2ML1IV
* Swiss dental implant maker Straumann STMN.S raised its
full-year organic revenue growth guidance as it reported
better-than-expected quarterly results on Thursday, saying that
customers are prioritizing spending on dental health.
urn:newsml:reuters.com:*:nL8N2MM0NQ
* HIAG Immobilien HIAG.S appoints Rico Müller as CFO
urn:newsml:reuters.com:*:nFWN2ML1F9
* US FDA Advisory Committee votes in favour of maintaining
accelerated approval of Roche's ROG.S Tecentriq for previously
untreated metastatic bladder cancer urn:newsml:reuters.com:*:nASN0014LY
* Achiko's ACHIN.S JV Partner obtains distribution
certificate for Aptamex in Indonesia urn:newsml:reuters.com:*:nFWN2ML1LR
* Sulzer SUN.S reported Q1 sales up 10% urn:newsml:reuters.com:*:nFWN2ML1LT
* Santhera SANN.S FY net loss widens to 67.7 million
francs urn:newsml:reuters.com:*:nASN0014O2
* STMicroelectronics STM.BN reported a rise in Q1 net
profit to $364 Mln urn:newsml:reuters.com:*:nASA022E3
* Vifor Pharma VIFN.S and Angion announce completion of
enrolment in Phase-II study of Ang-3777 urn:newsml:reuters.com:*:nASN0014NY
ECONOMY
No major Swiss economic data scheduled.
(Reporting by Zurich newsroom and Berlin Speed Desk)
((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German .SDE
All SMI constituent stocks 0#.SSMI
DJ STOXX index .STOXX
Top 10 STOXX sectors .PGL.STOXXS
Top 10 EUROSTOXX sectors .PGL.STOXXES
Swiss mid-cap index .SSMI
Swiss all-share index .SSHI
Swiss market digest .AD.S
Sector overview CH/SECTOR1
All Swiss news CH
Swiss research news CH-RCH
All equity news E
SPEED GUIDES: EQUITY EQUITY/NEWS1 EUR/EQUITY SWITZERLAND REUTERS ))